Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP

Last updated on 2017-12-21 History
Report ID 29312
Drug Identification Number 02250276
Brand name CEFTRIAXONE SODIUM FOR INJECTION, BP
Common or Proper name Ceftriaxone sodium
Company Name PFIZER CANADA ULC
Active Ingredient(s) CEFTRIAXONE
Strength(s) 250MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10x250mg vial
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-13
Estimated end date
Actual end date 2017-12-20
Shortage status Resolved
Updated date 2017-12-21
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-02-02 English Compare
v10 2017-12-21 French Compare
v9 2017-12-21 English Compare
v8 2017-12-21 French Compare
v7 2017-12-21 English Compare
v6 2017-12-14 French Compare
v5 2017-12-14 English Compare
v4 2017-11-25 English Compare
v3 2017-11-15 French Compare
v2 2017-11-15 English Compare
v1 2017-11-15 English Compare